Ascendis Pharma A/S

Ascendis Pharma A/S

95.22
BRL
+0.81
(+0.86%)
4.74EPS
15.67P/E
83.75BMarket Cap
Feb 17Next Earn

Ascendis Pharma A/S Documents

Q2 FY2024 · Presentation 2

Ascendis Pharma A/S - Investor Update - Conference Call Deck · 20 pages

Read Ascendis Pharma A/S's results firsthand

Preview the first 2 pages of this presentation
Create a free account to start reading

Full documents are included with Professional

Q2 FY2024 documents